Author:
Lawrence Alexandra,Dilley James
Publisher
Springer International Publishing
Reference73 articles.
1. Surveillance, Epidemiology and ER (SEER) Program. SEER*Stat Data-base: incidence-SEER 13 Regs Research DATA. Natl Cancer Institute. Div Cancer Control Popul Sci Surveill Res Progr. 2017;66(1):7–30.
2. Prat J, FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124:1–5.
3. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. J Am Med Assoc. 2004;291(22):2705–12.
4. Barclay M, Gildea C, Poole J, Hirschowitz L, Menon U, Nordin A. Factors affecting short-term mortality in women with ovarian, tubal, or primary peritoneal cancer. Int J Gynecol Cancer. 2016;26(1):56–65.
5. Allen VA, Takashima Y, Nayak S, Manahan KJ, Geisler JP. Assessment of false-negative ascites cytology in epithelial ovarian carcinoma: a study of 313 patients. Am J Clin Oncol. 2017;40(2):175–7.